AUA2021 featured a wide range of content that is now available to be viewed on-demand. The following educational activities are available thanks in part to our industry sponsors. Explore and view Instructional Courses, Live From AUA2021 Highlights, and Satellite Symposia.
Kick-Off Weekend
Instructional Courses
Live From AUA2021
Satellite Symposia
Kick-Off Weekend
|
Contemporary Pharmacotherapy for OAB 2021: Monotherapy and Combined Pharmacotherapy to Optimize Treatment Support provided by independent educational grants from AbbVie, Astellas, Medtronic, Urovant Sciences, Inc. |
|
Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer Support provided by independent educational grants from AstraZeneca, Bristol Myers Squibb and Merck. |
|
Trimodality Therapy for Management of Muscle Invasive Bladder Cancer Support provided by independent educational grants from AstraZeneca, Bristol Myers Squibb and Merck. |
|
Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider Support provided by independent educational grants from Amgen, Astellas, AstraZeneca, Bristol Myers Squibb, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Merck, Pfizer, Inc. and Sanofi Genzyme. |
|
Incorporating Genomic Testing For Prostate Cancer into Your Practice Support provided by independent educational grants from Amgen, Astellas, AstraZeneca, Bristol Myers Squibb, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Merck, Pfizer, Inc. and Sanofi Genzyme. |
Instructional Courses
|
Genetic Testing in Prostate Cancer: Understanding Clinical Implications for Early Detection, Localized Disease, & Castration Resistant Prostate Cancer Support provided by independent educational grants from Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Exact Sciences Corporation, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Merck, Pfizer, Inc. and Sanofi Genzyme. |
|
Refractory Overactive Bladder: How to Select 3rd Line Therapies and Optimize Outcomes Support provided by independent educational grants from Astellas, AbbVie, Medtronic and Urovant Sciences, Inc. |
|
Renal Cell Carcinoma: Surgical & Medical Management of High-Risk Renal Cell Carcinoma: New Paradigms for Treatment Support provided by independent educational grants from AstraZeneca, Bristol-Myers Squibb and Merck. |
|
AUA Guidelines on Advanced/Metastatic/Castration Resistant Prostate Cancer Support provided by independent educational grants from Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Exact Sciences Corporation, Janssen Biotech, Inc. Administered by Janssen Scientific Affairs, LLC, Merck, Pfizer, Inc. and Sanofi Genzyme. |
|
What's New in the Management of Hormone Naïve & Castrate Resistant Prostate Cancer: A Case-based Session for Urologists, Advanced Practice Providers and Teams Support provided by independent educational grants from Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Exact Sciences Corporation, Janssen Biotech, Inc. Administered by Janssen Scientific Affairs, LLC, Merck, Pfizer, Inc., and Sanofi Genzyme. |
|
Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems Support provided by independent educational grants from AstraZeneca, Bristol-Myers Squibb and Merck. |
Live From AUA2021
Satellite Symposium
5th Annual Mount Sinai Innovations in Robotic Surgery
New Treatment Strategies and Considerations in OAB to Improve Patient Outcomes
PSMA-Targeted PET Imaging and Interpretation: What Urologists Need to Know